Transfusion‐associated microchimerism

Blood transfusion is a newly recognized cause of microchimerism, the stable persistence of a minor population of allogeneic cells. Relatively recent advances in polymerase chain reaction technology have spawned new information about the frequency and aetiology of transfusion‐associated microchimerism (TA‐MC). Although conceptually related to fetal‐maternal microchimerism, TA‐MC is a distinct and separate entity. Evidence of TA‐MC has been strongest among patients with severe traumatic injuries who receive relatively fresh blood products shortly after an episode of massive haemorrhage. The presence of a focal deficit in the cellular immunologic repertoire prior to transfusion that happens to match a blood donor's human leucocyte antigen type also appears to be an important predisposing factor. TA‐MC seems to be common (affecting approximately 10% of transfused injured patients), enduring (lasting years to decades) and pronounced (involving up to 5% of circulating leucocytes and multiple immunophenotypic lineages suggestive of haematopoietic engraftment). Further study of this topic may reveal important information regarding potential clinical consequences of TA‐MC, as well as basic haematologic and immunologic processes.

[1]  D. L. Hutchinson,et al.  Chimerism following fetal transfusion. Report of leucocyte hybridization and infant with acute lymphocytic leukaemia. , 2009, Scandinavian journal of haematology.

[2]  B. Lubin,et al.  Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction , 2008, Transfusion.

[3]  P. Bingley,et al.  Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet β cell microchimerism , 2007, Proceedings of the National Academy of Sciences.

[4]  M. Busch,et al.  Enhanced ascertainment of microchimerism with real‐time quantitative polymerase chain reaction amplification of insertion‐deletion polymorphisms , 2006, Transfusion.

[5]  A. Nathens,et al.  Leukoreduction of blood transfusions does not diminish transfusion‐associated microchimerism in trauma patients , 2006, Transfusion.

[6]  M. Busch,et al.  Tracking microchimeric DNA in plasma to diagnose and manage organ transplant rejection. , 2006, Clinical chemistry.

[7]  M. Busch,et al.  High‐level long‐term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury , 2005, Transfusion.

[8]  M. Busch,et al.  Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. , 2005, The Journal of trauma.

[9]  M. Busch,et al.  Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. , 2004, The Journal of trauma.

[10]  K. M. Adams,et al.  Microchimerism: an investigative frontier in autoimmunity and transplantation. , 2004, JAMA.

[11]  D. Furst,et al.  Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. , 2004, Arthritis and rheumatism.

[12]  S. Heimfeld,et al.  Male DNA in female donor apheresis and CD34-enriched products. , 2003, Blood.

[13]  K. Mukherjee,et al.  Restriction fragment length polymorphism and polymerase chain reaction: HLA-DQA1 and polymarker analysis of blood samples from transfusion recipients. , 2002, American journal of clinical pathology.

[14]  M. Bernard,et al.  Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. , 2002, Blood.

[15]  J. Nelson,et al.  Microchimerism: incidental byproduct of pregnancy or active participant in human health? , 2002, Trends in molecular medicine.

[16]  Stephanie L. Lee,et al.  Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study , 2001, The Lancet.

[17]  Y. Lo,et al.  Fetomaternal Cellular and Plasma DNA Trafficking , 2001 .

[18]  T. Ohtsuka,et al.  Quantitative analysis of microchimerism in systemic sclerosis skin tissue , 2001, Archives of Dermatological Research.

[19]  D. Furst,et al.  Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. , 2001, Arthritis and rheumatism.

[20]  M. Lederman,et al.  Survival of transfused donor white blood cells in HIV-infected recipients. , 2001, Blood.

[21]  M. Busch,et al.  Donor WBCs can persist and transiently mediateimmunologic function in a murine transfusion model:effects of irradiation, storage, and histocompatibility , 2001, Transfusion.

[22]  K. Tsubota,et al.  Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome , 2001, Annals of the rheumatic diseases.

[23]  M. Busch,et al.  Detection of microchimerism by PCR is a function of amplification strategy , 2001, Transfusion.

[24]  T. Simon,et al.  Immune response to blood transfusion in very‐low‐birthweight infants , 2001, Transfusion.

[25]  C. Gassner,et al.  Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions , 2000, Transfusion.

[26]  F. Claas,et al.  Survival of donor cells 25 years after intrauterine transfusion. , 2000, Blood.

[27]  M. E. Reid,et al.  DNA from blood samples can be used to genotype patients who have recently received a transfusion , 2000, Transfusion.

[28]  J. Wang-Rodriguez,et al.  Immune response to blood transfusion invery‐low‐birthweight infants , 2000, Transfusion.

[29]  K. Batts,et al.  Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis , 1999, Hepatology.

[30]  D. Furst,et al.  Microchimerism of maternal origin persists into adult life. , 1999, The Journal of clinical investigation.

[31]  Tzong-Hae Lee,et al.  Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. , 1999, Blood.

[32]  E. Remmerswaal,et al.  Long‐term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion , 1998, British journal of haematology.

[33]  S. Jimenez,et al.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. , 1998, The New England journal of medicine.

[34]  D. Furst,et al.  Microchimerism and HLA-compatible relationships of pregnancy in scleroderma , 1998, The Lancet.

[35]  R. Wenk,et al.  DNA typing of recipient blood after massive transfusion , 1997, Transfusion.

[36]  A. Kibbi,et al.  Transfusion‐associated graft‐versus‐host disease: a report of three cases in immunocompetent patients in Lebanon , 1996, Transfusion.

[37]  G. Weil,et al.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Tadokoro,et al.  Analysis of risk factors for post-transfusion graft-versus-host disease in Japan , 1994, The Lancet.

[39]  D. Reardon,et al.  Detection of circulating donor white blood cells in patients receiving multiple transfusions. , 1992, Blood.

[40]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[41]  T. Juji,et al.  Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. , 1989, The New England journal of medicine.

[42]  Leonore A. Herzenberg,et al.  Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Whang‐Peng,et al.  Circulation of donor lymphocytes after blood transfusion in man. , 1977, Blood.

[44]  E. R. Schlesinger,et al.  Persistence of donor cells in neonates after fetal and exchange transfusion. , 1971, American journal of obstetrics and gynecology.

[45]  H. Muchmore,et al.  Transfer of delayed hypersensitivity. The role of blood transfusions in humans. , 1969, JAMA.

[46]  R. Owen.  IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS. , 1945, Science.

[47]  M. Busch,et al.  Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. , 2007, Seminars in hematology.

[48]  D. Bianchi,et al.  Maternal cell microchimerism in newborn tissues. , 2003, The Journal of pediatrics.

[49]  Y. Lo,et al.  Fetomaternal cellular and plasma DNA trafficking: the Yin and the Yang. , 2001, Annals of the New York Academy of Sciences.

[50]  S. Gennaro.  Very low birthweight infants , 1993 .